IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:IVG - NL0015000LU4 - Common Stock
18.8 EUR
0 (0%)
We assign a fundamental rating of 4 out of 10 to IVG. IVG was compared to 109 industry peers in the Machinery industry. There are concerns on the financial health of IVG while its profitability can be described as average. IVG has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year IVG was profitable.
IVG had a positive operating cash flow in the past year.
IVG had positive earnings in 4 of the past 5 years.
Each year in the past 5 years IVG had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 1.73%, IVG perfoms like the industry average, outperforming 41.28% of the companies in the same industry.
The Return On Equity of IVG (12.39%) is better than 73.39% of its industry peers.
IVG's Return On Invested Capital of 4.53% is in line compared to the rest of the industry. IVG outperforms 43.12% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IVG is below the industry average of 8.86%.
The 3 year average ROIC (3.91%) for IVG is below the current ROIC(4.53%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROIC | 4.53% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
1.3 Margins
IVG has a Profit Margin of 2.17%. This is in the lower half of the industry: IVG underperforms 61.47% of its industry peers.
In the last couple of years the Profit Margin of IVG has grown nicely.
IVG has a Operating Margin of 5.00%. This is comparable to the rest of the industry: IVG outperforms 41.28% of its industry peers.
In the last couple of years the Operating Margin of IVG has grown nicely.
The Gross Margin of IVG (16.49%) is worse than 90.83% of its industry peers.
In the last couple of years the Gross Margin of IVG has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% |
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IVG is destroying value.
The number of shares outstanding for IVG has been reduced compared to 1 year ago.
The number of shares outstanding for IVG has been increased compared to 5 years ago.
IVG has a better debt/assets ratio than last year.
2.2 Solvency
IVG has an Altman-Z score of 1.77. This is a bad value and indicates that IVG is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of IVG (1.77) is comparable to the rest of the industry.
The Debt to FCF ratio of IVG is 14.82, which is on the high side as it means it would take IVG, 14.82 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 14.82, IVG is doing worse than 71.56% of the companies in the same industry.
IVG has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
IVG has a worse Debt to Equity ratio (1.35) than 82.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Altman-Z | 1.77 |
ROIC/WACC0.62
WACC7.27%
2.3 Liquidity
A Current Ratio of 1.98 indicates that IVG should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.98, IVG is doing good in the industry, outperforming 73.39% of the companies in the same industry.
A Quick Ratio of 1.40 indicates that IVG should not have too much problems paying its short term obligations.
IVG has a Quick ratio of 1.40. This is in the better half of the industry: IVG outperforms 78.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 |
3. Growth
3.1 Past
IVG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.43%.
Measured over the past years, IVG shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.82% on average per year.
Looking at the last year, IVG shows a decrease in Revenue. The Revenue has decreased by -7.24% in the last year.
IVG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.06% yearly.
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
3.2 Future
Based on estimates for the next years, IVG will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.81% on average per year.
IVG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.30% yearly.
EPS Next Y-22.36%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
EPS Next 5Y10.81%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 14.03 indicates a correct valuation of IVG.
Based on the Price/Earnings ratio, IVG is valued cheaply inside the industry as 83.49% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.87. IVG is valued slightly cheaper when compared to this.
IVG is valuated reasonably with a Price/Forward Earnings ratio of 8.72.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IVG indicates a rather cheap valuation: IVG is cheaper than 91.74% of the companies listed in the same industry.
IVG is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.46, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.03 | ||
| Fwd PE | 8.72 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IVG indicates a somewhat cheap valuation: IVG is cheaper than 77.06% of the companies listed in the same industry.
68.81% of the companies in the same industry are more expensive than IVG, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.75 | ||
| EV/EBITDA | 5.57 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.43
EPS Next 2Y1.82%
EPS Next 3Y8.15%
5. Dividend
5.1 Amount
IVG has a Yearly Dividend Yield of 1.76%. Purely for dividend investing, there may be better candidates out there.
IVG's Dividend Yield is a higher than the industry average which is at 1.55.
Compared to an average S&P500 Dividend Yield of 1.94, IVG has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.76% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
27.33% of the earnings are spent on dividend by IVG. This is a low number and sustainable payout ratio.
DP27.33%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
BIT:IVG (1/6/2026, 5:36:15 PM)
18.8
0 (0%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners33.94%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.10B
Revenue(TTM)14.48B
Net Income(TTM)322.00M
Analysts72.31
Price Target20.11 (6.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.76% |
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP27.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-15.44%
Max EPS beat(2)5.84%
EPS beat(4)3
Avg EPS beat(4)15.3%
Min EPS beat(4)-15.44%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)15.63%
EPS beat(12)8
Avg EPS beat(12)16.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-10.1%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-10.1%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-3.62%
EPS NY rev (3m)-13.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.49%
Revenue NY rev (3m)-3.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.03 | ||
| Fwd PE | 8.72 | ||
| P/S | 0.34 | ||
| P/FCF | 12.75 | ||
| P/OCF | 3.96 | ||
| P/B | 1.96 | ||
| P/tB | 9.24 | ||
| EV/EBITDA | 5.57 |
EPS(TTM)1.34
EY7.13%
EPS(NY)2.16
Fwd EY11.47%
FCF(TTM)1.47
FCFY7.84%
OCF(TTM)4.75
OCFY25.28%
SpS54.61
BVpS9.58
TBVpS2.04
PEG (NY)N/A
PEG (5Y)0.43
Graham Number17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROCE | 6% | ||
| ROIC | 4.53% | ||
| ROICexc | 5.79% | ||
| ROICexgc | 7.34% | ||
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% | ||
| FCFM | 2.7% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexgc growth 3Y26.65%
ROICexgc growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Debt/EBITDA | 2.37 | ||
| Cap/Depr | 119.97% | ||
| Cap/Sales | 6% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 86.98% | ||
| Profit Quality | 124.22% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 1.77 |
F-Score6
WACC7.27%
ROIC/WACC0.62
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
EPS Next Y-22.36%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%
EBIT growth 1Y-21.25%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year64.49%
EBIT Next 3Y27.62%
EBIT Next 5YN/A
FCF growth 1Y-7.83%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-0.31%
OCF growth 3Y26.42%
OCF growth 5Y8.96%
IVECO GROUP NV / IVG.MI FAQ
Can you provide the ChartMill fundamental rating for IVECO GROUP NV?
ChartMill assigns a fundamental rating of 4 / 10 to IVG.MI.
What is the valuation status for IVG stock?
ChartMill assigns a valuation rating of 5 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for IVECO GROUP NV?
IVECO GROUP NV (IVG.MI) has a profitability rating of 5 / 10.
How financially healthy is IVECO GROUP NV?
The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.
Can you provide the expected EPS growth for IVG stock?
The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to decline by -22.36% in the next year.